Detailed explanation of obeticholic acid applicable groups and precautions

Obeticholic Acid (Obeticholic Acid), as a farnesoid X receptor agonist, has shown significant efficacy in the treatment of primary biliary cholangitis (PBC) in recent years. It indirectly inhibits CYP7A1, a key enzyme in cholic acid synthesis, by activating farnesoid X receptors, thereby inhibiting cholic acid synthesis and improving liver conditions.

1. Applicable people

Patients with primary biliary cholangitis: Obeticholic acid is the first drug approved by the FDA in the past 20 years for the treatment of primary biliary cholangitis. This disease is common in middle-aged and elderly women. It is caused by bile duct dysplasia or bile acid metabolism disorder, and can easily progress to liver fibrosis and cirrhosis. Obeticholic acid is particularly indicated for the treatment of adult patients with primary cholangitis (PBC) without cirrhosis or with compensated cirrhosis without evidence of portal hypertension. Either in combination with ursodeoxycholic acid (UDCA) in patients who have inadequate response to UDCA, or as monotherapy in patients who cannot tolerate UDCA.

2. Precautions

1. Strictly follow medical instructions: Obeticholic acid should be used under the guidance of a doctor to ensure the accuracy of dosage and medication time. Patients need to have their liver function tested regularly to monitor liver status and drug effects.

2. Pay attention to side effects: Obeticholic acid may cause a series of side effects, including itching, fatigue, abdominal pain, dry mouth, jaundice, and high cholesterol. Among them, itching is the most common side effect. If the symptoms are severe, you should seek medical treatment in time.

3. Drug interactions: Obeticholic acid may interact with other drugs. Patients should inform their doctors of all drugs they are taking before taking it to avoid potential drug risks. In particular, drugs such as colesevelam, cholestyramine or colestipol should be avoided within 4 hours before and after taking obeticholic acid.

4. Regular medication use and monitoring: Patients should take obeticholic acid regularly and choose to take the medication at a fixed time every day to avoid missing doses or overdose. At the same time, liver function tests need to be performed regularly, and the medication regimen should be adjusted based on the results.

5. Avoid stopping the medication on your own: Unless advised by a doctor, patients should not stop taking obeticholic acid without authorization, so as not to affect the therapeutic effect or cause rebound acidity.

6. Drug storage: Obeticholic acid should be stored in a room temperature, dry, cool, and ventilated place, avoiding direct sunlight and high temperatures to ensure that the drug is used within the validity period.

In summary, obeticholic acid, as a new treatment drug for liver diseases, provides a new treatment option for patients with primary biliary cholangitis and non-alcoholic steatohepatitis. However, patients should strictly follow medical instructions when using it, and pay attention to monitoring side effects and drug interactions to ensure the effectiveness and safety of the drug. Currently, obeticholic acid is available in both original and generic versions. Patients should choose according to their needs.